Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Endocrine-Related Cancer|May 1, 2016
Androgen control of lipid metabolism in prostate cancer: novel insights and future applicationsLisa M Butler, Margaret M Centenera, Johannes V Swinnen
Molecular Cancer Research : MCR|March 3, 2026
Connecting the cell cycle to lipid metabolism in cancer: Their reciprocal roles and opportunity for therapeutic exploitationJoshua T Hodgson, Lisa M Butler, Margaret M Centenera
Molecular Endocrinology (Baltimore, Md.)|July 12, 2008
The contribution of different androgen receptor domains to receptor dimerization and signalingMargaret M Centenera, Jonathan M Harris, Wayne D Tilley, et al.
Biochimica Et Biophysica Acta|January 5, 2013
Hsp90: still a viable target in prostate cancerMargaret M Centenera, Alyssa K Fitzpatrick, Wayne D Tilley, et al.
Molecular Cancer Research : MCR|July 30, 2015
Maximizing the Therapeutic Potential of HSP90 InhibitorsLisa M Butler, Roberta Ferraldeschi, Heather K Armstrong, et al.
Cold Spring Harbor Perspectives in Medicine|March 14, 2018
New Opportunities for Targeting the Androgen Receptor in Prostate CancerMargaret M Centenera, Luke A Selth, Esmaeil Ebrahimie, et al.
Plos One|October 8, 2011
GSTP1 DNA methylation and expression status is indicative of 5-aza-2'-deoxycytidine efficacy in human prostate cancer cellsKaren Chiam, Margaret M Centenera, Lisa M Butler, et al.
Frontiers in Oncology|August 29, 2022
The role of RHAMM in cancer: Exposing novel therapeutic vulnerabilitiesJosephine A Hinneh, Joanna L Gillis, Nicole L Moore, et al.
Nature Reviews. Urology|June 12, 2013
Ex vivo culture of human prostate tissue and drug developmentMargaret M Centenera, Ganesh V Raj, Karen E Knudsen, et al.
Expert Review of Clinical Pharmacology|November 25, 2011
Finding the place of histone deacetylase inhibitors in prostate cancer therapyDeborah L Marrocco-Tallarigo, Margaret M Centenera, Howard I Scher, et al.
Pageof 5